Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Sees Large Drop in Short Interest
by Amy Steele · The Cerbat GemBioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 760,633 shares, a drop of 25.4% from the December 31st total of 1,019,948 shares. Currently, 1.2% of the company’s shares are sold short. Based on an average daily volume of 554,063 shares, the days-to-cover ratio is currently 1.4 days. Based on an average daily volume of 554,063 shares, the days-to-cover ratio is currently 1.4 days. Currently, 1.2% of the company’s shares are sold short.
Bioceres Crop Solutions Stock Performance
Shares of NASDAQ:BIOX traded down $0.09 on Tuesday, reaching $0.78. 58,990 shares of the company’s stock were exchanged, compared to its average volume of 595,488. The business’s 50-day moving average is $1.37 and its two-hundred day moving average is $1.97. The company has a quick ratio of 0.64, a current ratio of 0.94 and a debt-to-equity ratio of 0.19. Bioceres Crop Solutions has a fifty-two week low of $0.83 and a fifty-two week high of $6.86. The firm has a market capitalization of $49.26 million, a price-to-earnings ratio of -0.98 and a beta of 0.50.
Institutional Investors Weigh In On Bioceres Crop Solutions
Several hedge funds have recently made changes to their positions in BIOX. Susquehanna International Group LLP bought a new position in shares of Bioceres Crop Solutions during the 3rd quarter valued at $315,000. Virtu Financial LLC acquired a new position in Bioceres Crop Solutions during the third quarter worth $40,000. Squarepoint Ops LLC bought a new position in Bioceres Crop Solutions during the third quarter valued at about $233,000. PDT Partners LLC lifted its position in shares of Bioceres Crop Solutions by 58.9% in the second quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after buying an additional 10,449 shares during the last quarter. Finally, Jane Street Group LLC bought a new stake in shares of Bioceres Crop Solutions during the 2nd quarter worth about $202,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.
Analyst Upgrades and Downgrades
BIOX has been the subject of a number of research reports. Canaccord Genuity Group decreased their target price on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a report on Friday, January 2nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. Oppenheimer downgraded shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research note on Wednesday, October 22nd. Finally, Wall Street Zen raised shares of Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $4.00.
Read Our Latest Report on BIOX
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.